Bio-Rad Laboratories, Inc. Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc.

BIO

Classifica tra le azioni #2127
Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules,... Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.
Prezzo delle azioni
$361.07
Capitalizzazione di mercato
$9.65B
Variazione (1 giorno)
1.78%
Variazione (1 anno)
9.00%
Paese
US
Scambia Bio-Rad Laboratories, Inc. (BIO)

Categoria

Healthcare
Storico del prezzo dell'azione per Bio-Rad Laboratories, Inc. (BIO)
Prezzo di chiusura più alto: $363.01 il 2026-10-01

Prezzo di chiusura più basso: $2.58 il 1980-02-01
Storico del prezzo dell'azione di Bio-Rad Laboratories, Inc. dal 1980 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 1.02%
2025 -7.38%
2024 6.75%
2023 -24.70%
2022 -44.52%
2021 30.76%
2020 56.22%
2019 49.95%
2018 -2.37%
2017 38.56%
2016 30.79%
2015 14.98%
2014 -2.17%
2013 16.54%
2012 12.33%
2011 -8.03%
2010 4.71%
2009 38.69%
2008 -31.59%
2007 24.99%
2006 30.49%
2005 8.47%
2004 9.92%
2003 29.94%
2002 27.48%
2001 101.21%
2000 32.53%
1999 13.72%
1998 -15.82%
1997 -14.40%
1996 6.99%
1995 50.68%
1994 153.63%
1993 -39.35%
1992 -4.70%
1991 6.42%
1990 12.52%
1989 -12.63%
1988 33.99%
1987 -24.29%
1986 16.67%
1985 133.07%
1984 -14.67%
1983 87.50%
1982 -3.36%
1981 -45.76%
1980 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$100.56 -21.15%
US
$93.07 -2.88%
IE
$297.13 -21.76%
US
$44.47 -55.49%
US
$46.69 -17.17%
DE